Administration, Cutaneous
"Administration, Cutaneous" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The application of suitable drug dosage forms to the skin for either local or systemic effects.
Descriptor ID |
D000279
|
MeSH Number(s) |
E02.319.267.120.060
|
Concept/Terms |
Administration, Cutaneous- Administration, Cutaneous
- Cutaneous Administration, Drug
- Cutaneous Administrations, Drug
- Drug Administration, Cutaneous
- Administration, Cutaneous Drug
- Administrations, Cutaneous Drug
- Cutaneous Drug Administrations
- Drug Administrations, Cutaneous
- Cutaneous Drug Administration
- Dermal Administration
- Drug Administration, Dermal
- Skin Administration, Drug
- Drug Skin Administrations
- Skin Administrations, Drug
- Skin Drug Administration
- Skin Drug Administrations
- Administration, Dermal
- Administrations, Dermal
- Dermal Administrations
- Cutaneous Administration
- Administrations, Cutaneous
- Cutaneous Administrations
- Dermal Drug Administration
- Administration, Dermal Drug
- Administrations, Dermal Drug
- Dermal Drug Administrations
- Drug Administrations, Dermal
Administration, Transcutaneous- Administration, Transcutaneous
- Administrations, Transcutaneous
- Transcutaneous Administrations
- Administration, Transdermal
- Administrations, Transdermal
- Transdermal Administrations
- Transdermal Administration
- Transcutaneous Administration
Percutaneous Administration- Percutaneous Administration
- Administration, Percutaneous
- Administrations, Percutaneous
- Percutaneous Administrations
|
Below are MeSH descriptors whose meaning is more general than "Administration, Cutaneous".
Below are MeSH descriptors whose meaning is more specific than "Administration, Cutaneous".
This graph shows the total number of publications written about "Administration, Cutaneous" by people in this website by year, and whether "Administration, Cutaneous" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1998 | 0 | 1 | 1 |
2000 | 0 | 1 | 1 |
2001 | 0 | 1 | 1 |
2002 | 0 | 1 | 1 |
2004 | 0 | 1 | 1 |
2005 | 0 | 2 | 2 |
2007 | 0 | 2 | 2 |
2008 | 0 | 1 | 1 |
2009 | 0 | 1 | 1 |
2010 | 0 | 6 | 6 |
2011 | 0 | 1 | 1 |
2012 | 0 | 1 | 1 |
2013 | 0 | 3 | 3 |
2014 | 0 | 1 | 1 |
2015 | 0 | 1 | 1 |
2016 | 0 | 1 | 1 |
2018 | 0 | 2 | 2 |
2019 | 0 | 1 | 1 |
2020 | 0 | 1 | 1 |
2021 | 0 | 1 | 1 |
2022 | 0 | 1 | 1 |
2023 | 0 | 2 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Administration, Cutaneous" by people in Profiles.
-
Beaven E, Kumar R, An JM, Mendoza H, Sutradhar SC, Choi W, Narayan M, Lee YK, Nurunnabi M. Potentials of ionic liquids to overcome physical and biological barriers. Adv Drug Deliv Rev. 2024 Jan; 204:115157.
-
Bagde A, Dev S, Madhavi K Sriram L, Spencer SD, Kalvala A, Nathani A, Salau O, Mosley-Kellum K, Dalvaigari H, Rajaraman S, Kundu A, Singh M. Biphasic burst and sustained transdermal delivery in vivo using an AI-optimized 3D-printed MN patch. Int J Pharm. 2023 Apr 05; 636:122647.
-
Huda MN, Deaguero IG, Borrego EA, Kumar R, Islam T, Afrin H, Varela-Ramirez A, Aguilera RJ, Tanner EEL, Nurunnabi M. Ionic liquid-mediated delivery of a BCL-2 inhibitor for topical treatment of skin melanoma. J Control Release. 2022 09; 349:783-795.
-
Patel P, Pol A, Kalaria D, Date AA, Kalia Y, Patravale V. Microemulsion-based gel for the transdermal delivery of rasagiline mesylate: In vitro and in vivo assessment for Parkinson's therapy. Eur J Pharm Biopharm. 2021 Aug; 165:66-74.
-
Bardsley TA, Evans CL, Greene JR, Audet R, Harrison MJ, Zimmerman M, Nieto NC, Del Sesto RE, Koppisch AT, Kellar RS. Integration of choline geranate into electrospun protein scaffolds affords antimicrobial activity to biomaterials used for cutaneous wound healing. J Biomed Mater Res B Appl Biomater. 2021 09; 109(9):1271-1282.
-
Lu BY, Agapoff JR, Olson DJ, Williams SR, Roller A, Goebert D. Rapid and sustained improvement in treatment-refractory depression through use of acute intravenous ketamine and concurrent transdermal selegiline: A case series. J Affect Disord. 2020 02 01; 262:40-42.
-
Swaminathan SK, Fisher J, Brogden NK, Kandimalla KK. Development and validation of a sensitive LC-MS/MS method for the estimation of scopolamine in human serum. J Pharm Biomed Anal. 2019 Feb 05; 164:41-46.
-
Manfredi B, Morales-Ort?z J, D?az-D?az LM, Hernandez-Matias L, Barreto-V?zquez D, Men?ndez-P?rez J, Rodr?guez-Cordero JA, Villalobos-Santos JC, Santiago-Rivera E, Rivera-Dompenciel A, Lozada-Delgado EL, Kuchibhotla M, Carrasquillo-Carri?n K, Roche-Lima A, Washington AV. The Characterization of Monoclonal Antibodies to Mouse TLT-1 Suggests That TLT-1 Plays a Role in Wound Healing. Monoclon Antib Immunodiagn Immunother. 2018 Apr; 37(2):78-86.
-
Liu DJ, Collaku A, Dosik JS. Skin Irritation and Sensitization Potential of Fixed-Dose Combination of Diclofenac 1% and Menthol 3% Topical Gel: Results of Two Phase I Patch Studies. Drug Res (Stuttg). 2017 Feb; 67(2):119-126.
-
Han J, Saraf SL, Gordeuk VR, Gowhari M. Safety of chronic transdermal fentanyl use in patients receiving hemodialysis. Am J Health Syst Pharm. 2016 Jul 01; 73(13):947-8.